Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes

AIM: To assess the effects of dapagliflozin plus saxagliptin plus metformin versus glimepiride plus metformin on liver fat (proton density fat fraction) and visceral and subcutaneous adipose tissue volumes over 52 weeks of treatment. MATERIALS AND METHODS: This was a magnetic resonance imaging subst...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Johansson, Lars, Hockings, Paul D., Johnsson, Eva, Dronamraju, Nalina, Maaske, Jill, Garcia‐Sanchez, Ricardo, Wilding, John P. H.
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318158/
https://ncbi.nlm.nih.gov/pubmed/32072735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky